70 related articles for article (PubMed ID: 18776816)
1. Loss of annexin A1 expression in breast cancer progression.
Cao Y; Li Y; Edelweiss M; Arun B; Rosen D; Resetkova E; Wu Y; Liu J; Sahin A; Albarracin CT
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):530-4. PubMed ID: 18776816
[TBL] [Abstract][Full Text] [Related]
2. Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.
De Marchi T; Timmermans AM; Smid M; Look MP; Stingl C; Opdam M; Linn SC; Sweep FC; Span PN; Kliffen M; van Deurzen CH; Luider TM; Foekens JA; Martens JW; Umar A
Oncotarget; 2016 Jan; 7(3):3098-110. PubMed ID: 26657294
[TBL] [Abstract][Full Text] [Related]
3. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
Sobral-Leite M; Wesseling J; Smit VT; Nevanlinna H; van Miltenburg MH; Sanders J; Hofland I; Blows FM; Coulson P; Patrycja G; Schellens JH; Fagerholm R; Heikkilä P; Aittomäki K; Blomqvist C; Provenzano E; Ali HR; Figueroa J; Sherman M; Lissowska J; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Phillips KA; ; Couch FJ; Olson JE; Vachon C; Visscher D; Brenner H; Butterbach K; Arndt V; Holleczek B; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; van de Water B; Broeks A; Chang-Claude J; Chenevix-Trench G; Easton DF; Pharoah PD; García-Closas M; de Graauw M; Schmidt MK
BMC Med; 2015 Jul; 13():156. PubMed ID: 26137966
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Derived Matrix Metalloproteinase-13 (MMP-13) Expression in Benign and Malignant Breast Lesions.
Ameli F; Ghafourina Nassab F; Masir N; Kahtib F
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2603-2609. PubMed ID: 34452576
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Histone Deacetylase 3 (HDAC3) and Breast Cancer.
Cui Z; Xie M; Wu Z; Shi Y
Med Sci Monit; 2018 Apr; 24():2456-2464. PubMed ID: 29680858
[TBL] [Abstract][Full Text] [Related]
6. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells.
de Graauw M; van Miltenburg MH; Schmidt MK; Pont C; Lalai R; Kartopawiro J; Pardali E; Le Dévédec SE; Smit VT; van der Wal A; Van't Veer LJ; Cleton-Jansen AM; ten Dijke P; van de Water B
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6340-5. PubMed ID: 20308542
[TBL] [Abstract][Full Text] [Related]
7. Advanced hormone receptor-positive/human epidermal growth factor receptor 2-positive invasive ductal carcinoma with cecal metastasis: A case report.
Yang SY; Zhang J; Yang ZQ; Duan JJ; Zhang Y; Li MK; Wang L; Ye CM; Nie JY
Sci Prog; 2023; 106(4):368504231201043. PubMed ID: 37828835
[TBL] [Abstract][Full Text] [Related]
8. The role of ANXA1 in the tumor microenvironment.
Li L; Wang B; Zhao S; Xiong Q; Cheng A
Int Immunopharmacol; 2024 Apr; 131():111854. PubMed ID: 38479155
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of ARID1A and ANXA1 in HER-2 Positive Breast Cancer.
Silva-Oliveira R; Pereira FF; Petronilho S; Martins AT; Lameirinhas A; Constâncio V; Caldas-Ribeiro I; Salta S; Lopes P; Antunes L; Castro F; de Sousa SP; Henrique R; Jerónimo C
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33276477
[TBL] [Abstract][Full Text] [Related]
10. Annexin A1 expression and its prognostic significance in human breast cancer.
Wang LP; Bi J; Yao C; Xu XD; Li XX; Wang SM; Li ZL; Zhang DY; Wang M; Chang GQ
Neoplasma; 2010; 57(3):253-9. PubMed ID: 20353277
[TBL] [Abstract][Full Text] [Related]
11. Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer.
Okano M; Kumamoto K; Saito M; Onozawa H; Saito K; Abe N; Ohtake T; Takenoshita S
Oncol Rep; 2015 Mar; 33(3):1064-70. PubMed ID: 25592491
[TBL] [Abstract][Full Text] [Related]
12. Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer.
Bai F; Zhang P; Fu Y; Chen H; Zhang M; Huang Q; Li D; Li B; Wu K
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32300050
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis of Novel Targets for Treating Cervical Cancer by Immunotherapy Based on Immune Escape.
Han YH; Ma DY; Lee SJ; Mao YY; Sun SY; Jin MH; Sun HN; Kwon T
Cancer Genomics Proteomics; 2023; 20(4):383-397. PubMed ID: 37400149
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy.
Li R; Cao L
Front Immunol; 2023; 14():1194020. PubMed ID: 37275874
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation.
Su X; Wang G; Zheng S; Ge C; Kong F; Wang C
J Inflamm Res; 2023; 16():1325-1342. PubMed ID: 37006812
[TBL] [Abstract][Full Text] [Related]
17. ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.
Yu ZZ; Liu YY; Zhu W; Xiao D; Huang W; Lu SS; Yi H; Zeng T; Feng XP; Yuan L; Qiu JY; Wu D; Wen Q; Zhou JH; Zhuang W; Xiao ZQ
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 37001908
[TBL] [Abstract][Full Text] [Related]
18. Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.
Shi X; Wu Y; Tang L; Ni H; Xu Y
Aging (Albany NY); 2023 Mar; 15(6):2321-2346. PubMed ID: 36988561
[TBL] [Abstract][Full Text] [Related]
19. A Cell-Based Systematic Review on the Role of Annexin A1 in Triple-Negative Breast Cancers.
Pearanpan L; Nordin FJ; Siew EL; Kumolosasi E; Mohamad Hanif EA; Masre SF; Chua EW; Cheng HS; Rajab NF
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897832
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
